SNYR Stock Forecast & Price Target

Synergy CHC Corp reported a 12% increase in net revenues, reaching $8.0 million, demonstrating a positive growth trajectory despite being approximately 27% below estimates. The company's focus on higher margin supplement revenue, which led to a gross margin of 67.2%, underscores its potential for enhanced profitability as it continues to expand its offerings. Additionally, with anticipated growth in its FOCUSfactor brand and strategic capital-raising initiatives, the company is expected to improve future visibility into sales, profits, and cash flows, which may benefit shareholder value.

Synergy CHC Corp reported an Adjusted EBITDA of $1.3 million, consistent with the prior year but significantly below the estimate of $2.4 million, largely attributed to tight cash flow prior to a recent equity raise. The company's revenue estimates have been revised downward, with expectations for 2025 lowered to $35.4 million from $43.2 million, reflecting a continued trend of shortfalls in financial performance. Additionally, ongoing economic challenges are projected to adversely impact consumer spending, further contributing to a weak and volatile share price over the past year.